Conneqt is a subsidiary of global health technology company CardieX, which specializes in producing biomarkers and digital solutions for vascular health disorders.
The Pulse is currently under review for FDA-clearance. It will work with a Conneqt app to deliver heart insights directly to user’s smartphones.
Data can also be shared directly with a patient’s physician for remote patient monitoring.
